Published in Bioorg Med Chem Lett on November 06, 2011
New β-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob Agents Chemother (2013) 1.47
The intrinsic resistome of bacterial pathogens. Front Microbiol (2013) 1.05
An Update on the Status of Potent Inhibitors of Metallo-β-Lactamases. Sci Pharm (2013) 0.83
Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors. ACS Med Chem Lett (2015) 0.79
Fragment-based inhibitor discovery against β-lactamase. Future Med Chem (2014) 0.76
Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors. ACS Med Chem Lett (2016) 0.75
Structural basis for proofreading during replication of the Escherichia coli chromosome. Structure (2002) 1.98
The catalytic mechanisms of binuclear metallohydrolases. Chem Rev (2006) 1.50
Alpha/beta hydrolase fold: an update. Protein Pept Lett (2009) 1.26
The structures of the PII proteins from the cyanobacteria Synechococcus sp. PCC 7942 and Synechocystis sp. PCC 6803. Acta Crystallogr D Biol Crystallogr (2003) 1.16
Comparing the organophosphorus and carbamate insecticide resistance mutations in cholin- and carboxyl-esterases. Chem Biol Interact (2005) 1.15
Anomalous scattering analysis of Agrobacterium radiobacter phosphotriesterase: the prominent role of iron in the heterobinuclear active site. Biochem J (2006) 1.14
Hydrolysis of the 5'-p-nitrophenyl ester of TMP by the proofreading exonuclease (epsilon) subunit of Escherichia coli DNA polymerase III. Biochemistry (2002) 1.14
In crystallo capture of a Michaelis complex and product-binding modes of a bacterial phosphotriesterase. J Mol Biol (2007) 1.09
The structure and function of a novel glycerophosphodiesterase from Enterobacter aerogenes. J Mol Biol (2007) 1.07
Growth of Escherichia coli coexpressing phosphotriesterase and glycerophosphodiester phosphodiesterase, using paraoxon as the sole phosphorus source. Appl Environ Microbiol (2004) 1.05
Rapid-freeze-quench magnetic circular dichroism of intermediate X in ribonucleotide reductase: new structural insight. J Am Chem Soc (2003) 1.00
D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity. Chembiochem (2003) 0.99
The effects of substrate orientation on the mechanism of a phosphotriesterase. Org Biomol Chem (2005) 0.98
5-Carb-oxy-2,4-dihy-droxy-anilinium chloride. Acta Crystallogr Sect E Struct Rep Online (2010) 0.97
Structure and function of an insect α-carboxylesterase (αEsterase7) associated with insecticide resistance. Proc Natl Acad Sci U S A (2013) 0.97
Diesterase activity and substrate binding in purple acid phosphatases. J Am Chem Soc (2007) 0.96
[2-(2,3-Dimethyl-anilino)phen-yl]methanol. Acta Crystallogr Sect E Struct Rep Online (2010) 0.96
2-(6-Meth-oxy-naphthalen-2-yl)-1-(morpholin-4-yl)propan-1-one. Acta Crystallogr Sect E Struct Rep Online (2012) 0.96
Improving a natural enzyme activity through incorporation of unnatural amino acids. J Am Chem Soc (2010) 0.96
The structure of an enzyme-product complex reveals the critical role of a terminal hydroxide nucleophile in the bacterial phosphotriesterase mechanism. Biochim Biophys Acta (2005) 0.96
Structure of the N-terminal domain of Escherichia coli glutamine synthetase adenylyltransferase. Structure (2004) 0.96
Identification of novel target sites and an inhibitor of the dengue virus E protein. J Comput Aided Mol Des (2009) 0.96
Methyl 2,4-dihy-droxy-5-(4-nitro-benzamido)-benzoate. Acta Crystallogr Sect E Struct Rep Online (2013) 0.92
Improving protein solubility: the use of the Escherichia coli dihydrofolate reductase gene as a fusion reporter. Protein Expr Purif (2005) 0.92
Binuclear metallohydrolases: complex mechanistic strategies for a simple chemical reaction. Acc Chem Res (2012) 0.90
Human tartrate-resistant acid phosphatase becomes an effective ATPase upon proteolytic activation. Arch Biochem Biophys (2005) 0.88
A novel functional epitope formed by domains 1 and 4 of the human common beta-subunit is involved in receptor activation by granulocyte macrophage colony-stimulating factor and interleukin 5. J Biol Chem (2003) 0.88
Interleukin-3 binding to the murine betaIL-3 and human betac receptors involves functional epitopes formed by domains 1 and 4 of different protein chains. J Biol Chem (2004) 0.87
Expression, purification, crystallization, and preliminary X-ray analysis of the N-terminal domain of Escherichia coli adenylyl transferase. Protein Expr Purif (2004) 0.86
Metal-ion mutagenesis: conversion of a purple acid phosphatase from sweet potato to a neutral phosphatase with the formation of an unprecedented catalytically competent Mn(II)Mn(II) active site. J Am Chem Soc (2009) 0.86
Structure of the adenylylation domain of E. coli glutamine synthetase adenylyl transferase: evidence for gene duplication and evolution of a new active site. J Mol Biol (2009) 0.85
Kinetic and spectroscopic studies of N694C lipoxygenase: a probe of the substrate activation mechanism of a nonheme ferric enzyme. J Am Chem Soc (2007) 0.84
Substrate-promoted formation of a catalytically competent binuclear center and regulation of reactivity in a glycerophosphodiesterase from Enterobacter aerogenes. J Am Chem Soc (2008) 0.84
Reactivity of M(II) metal-substituted derivatives of pig purple acid phosphatase (uteroferrin) with phosphate. Inorg Chem (2002) 0.83
Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatases. Arch Biochem Biophys (2004) 0.83
Phosphate-bound structure of an organophosphate-degrading enzyme from Agrobacterium radiobacter. J Inorg Biochem (2011) 0.83
Structural flexibility enhances the reactivity of the bioremediator glycerophosphodiesterase by fine-tuning its mechanism of hydrolysis. J Am Chem Soc (2009) 0.82
Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer. Biomacromolecules (2013) 0.82
Structural and functional analysis of a FeoB A143S G5 loop mutant explains the accelerated GDP release rate. FEBS J (2014) 0.82
Synthesis and kinetic testing of new inhibitors for a metallo-β-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. Eur J Med Chem (2011) 0.82
Following directed evolution with crystallography: structural changes observed in changing the substrate specificity of dienelactone hydrolase. Acta Crystallogr D Biol Crystallogr (2005) 0.82
Directed evolution combined with rational design increases activity of GpdQ toward a non-physiological substrate and alters the oligomeric structure of the enzyme. Protein Eng Des Sel (2011) 0.82
Advances in peptide-based human papillomavirus therapeutic vaccines. Curr Top Med Chem (2012) 0.81
An unprecedented Fe(III)(mu-OH)Zn(II) complex that mimics the structural and functional properties of purple acid phosphatases. J Am Chem Soc (2007) 0.81
The reaction mechanism of the Ga(III)Zn(II) derivative of uteroferrin and corresponding biomimetics. J Biol Inorg Chem (2007) 0.81
Synthesis, modelling and kinetic assays of potent inhibitors of purple acid phosphatase. Bioorg Med Chem Lett (2011) 0.81
Synthesis of nickel-chelating fluorinated lipids for protein monolayer crystallizations. J Org Chem (2009) 0.81
The domains carrying the opposing activities in adenylyltransferase are separated by a central regulatory domain. FEBS J (2007) 0.81
Bacterial and plant ketol-acid reductoisomerases have different mechanisms of induced fit during the catalytic cycle. J Mol Biol (2012) 0.81
Using directed evolution to improve the solubility of the C-terminal domain of Escherichia coli aminopeptidase P. Implications for metal binding and protein stability. FEBS J (2007) 0.81
Synthesis and characterization of the tetranuclear iron(III) complex of a new asymmetric multidentate ligand. A structural model for purple acid phosphatases. Dalton Trans (2007) 0.81
Mutation of outer-shell residues modulates metal ion co-ordination strength in a metalloenzyme. Biochem J (2010) 0.80
Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs). Curr Drug Deliv (2006) 0.80
The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening. Bioorg Med Chem Lett (2011) 0.80
Spectroscopic characterization of the active Fe(III)Fe(III) and Fe(III)Fe(II) forms of a purple acid phosphatase model system. Inorg Chem (2012) 0.80
Fermentative glycolysis with purified Escherichia coli enzymes for in vitro ATP production and evaluating an engineered enzyme. J Biotechnol (2011) 0.80
Phosphate ester cleavage promoted by a tetrameric iron(III) complex. J Biol Inorg Chem (2010) 0.79
Electronic and geometric structures of the organophosphate-degrading enzyme from Agrobacterium radiobacter (OpdA). J Biol Inorg Chem (2011) 0.79
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines. J Med Chem (2008) 0.79
Malonate-bound structure of the glycerophosphodiesterase from Enterobacter aerogenes (GpdQ) and characterization of the native Fe2+ metal-ion preference. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.79
The role of Zn-OR and Zn-OH nucleophiles and the influence of para-substituents in the reactions of binuclear phosphatase mimetics. Dalton Trans (2011) 0.79
Molecular packing of functionalized fluorinated lipids in Langmuir monolayers. Langmuir (2010) 0.79
Enhanced biocidal activity of Au nanoparticles synthesized in one pot using 2, 4-dihydroxybenzene carbodithioic acid as a reducing and stabilizing agent. J Nanobiotechnology (2013) 0.79
5-Carb-oxy-2,4-dihy-droxy-anilinium chloride dihydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.79
Pharmacokinetics of OpdA, an organophosphorus hydrolase, in the African green monkey. Biochem Pharmacol (2010) 0.79
Structural and catalytic characterization of a heterovalent Mn(II)Mn(III) complex that mimics purple acid phosphatases. Inorg Chem (2009) 0.79
Penicillin inhibitors of purple acid phosphatase. Bioorg Med Chem Lett (2012) 0.79
Electronic structure analysis of the dinuclear metal center in the bioremediator glycerophosphodiesterase (GpdQ) from Enterobacter aerogenes. Inorg Chem (2010) 0.79
Identification of purple acid phosphatase inhibitors by fragment-based screening: promising new leads for osteoporosis therapeutics. Chem Biol Drug Des (2012) 0.78
Substrate-induced conformational change and isomerase activity of dienelactone hydrolase and its site-specific mutants. Chembiochem (2012) 0.78
The organophosphate-degrading enzyme from Agrobacterium radiobacter displays mechanistic flexibility for catalysis. Biochem J (2010) 0.78
The purification, crystallization and preliminary diffraction of a glycerophosphodiesterase from Enterobacter aerogenes. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.78